Home › Cambridge biotech buys Pfizer assets and relaunches as Icagen
 

Keywords :   


Cambridge biotech buys Pfizer assets and relaunches as Icagen

2015-07-02 17:16:31| Biotech - Topix.net

A 12-year-old Cambridge biotech that changed its name last year from Caldera Pharmaceuticals to XRpro Sciences relaunched this morning with a third name - one that harkens back to a North Carolina biotech acquired by Pfizer a few years back. Icagen partners with pharmaceutical and biotechnology companies to offer scientific expertise and access to technologies for ion channel and transporter drug discovery and development.

Tags: assets cambridge biotech buys

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Forecast Discussion Number 15
07.11Hurricane Rafael Wind Speed Probabilities Number 15
07.11Hurricane Rafael Public Advisory Number 15
07.11Hurricane Rafael Forecast Advisory Number 15
07.11Tropical Depression Fourteen-E Public Advisory Number 4
07.11Summary for Tropical Depression Fourteen-E (EP4/EP142024)
07.11Tropical Depression Fourteen-E Graphics
More »